Objectives-To examine the repeatability of quantitative time-intensity curve analysis of neovascularization within carotid plaques with contrast-enhanced ultrasonography (US) and to investigate carotid plaque neovascularization in patients with coronary heart disease using contrast-enhanced US and the correlation between risk factors and acute coronary syndrome (ACS).
C oronary artery disease (CAD) is the leading cause of death in developed countries. Acute coronary syndrome (ACS) is a common form of CAD that is related to the rupture or erosion of coronary plaques. [1] [2] [3] Currently, neovascularization is considered the most powerful independent predictor of plaque rupture and hemorrhage, with a significant correlation with the occurrence of clinical cardiovascular events. 4 Atherothrombosis is a systemic disease of the arterial wall that affects the carotid, coronary, and peripheral vascular beds and the aorta. Carotid plaques have similar pathologic and physiologic bases as coronary plaques, and the stability of carotid plaques is closely associated with the occurrence of coronary heart disease (CHD). 5, 6 Therefore, early screening, diagnosis, risk assessment, and intervention of carotid plaques are of great importance. Due to its ability to detect neovascularization within plaques, contrast-enhanced ultrasonography (US) has introduced a new way of evaluating plaque vulnerability in clinical practice. 7, 8 In this study, contrast-enhanced US was applied to evaluate neovascularization in carotid plaques of patients with CHD and the correlation between the stability of carotid plaques and CHD.
Materials and Methods

Patient Population
The protocol was approved by the hospital Ethics Committee, and informed consent was obtained from all patients before their contrast-enhanced US examinations. A total of 120 consecutive study patients were prospectively enrolled at Union Hospital between April 1, 2014, and May 1, 2015. The patients were assigned to 2 groups according to symptoms and the diagnostic standards of the American Heart Association. 9 In the ACS group, there were 60 patients. The inclusive criteria were matched with 2003 American Heart Association criteria for ACS, 10 according to the symptoms of chest pain, clinical characteristics, electrocardiographic changes, myocardial enzymes levels, the treadmill exercise test, radionuclide myocardial perfusion imaging, and coronary angiographic results. Among those 60 patients, there were 20 cases of unstable angina, 21 cases of STsegment elevation myocardial infarction, and 19 cases of non-ST-segment elevation myocardial infarction.
Carotid contrast-enhanced US was performed within 1 month of ACS occurrence. The control group consisted of 60 age-matched patients with stable CAD. All patients were screened with B-mode carotid artery US, and carotid plaque thicknesses were larger than 2.0 mm. Exclusion criteria were patients with rheumatic heart disease, hyperthyroidism heart disease, myocarditis, cardiomyopathy, and hypertensive cardiomyopathy.
Apparatus
An iU22 Doppler US apparatus and a L9-3 transducer with a frequency of 5-9 MHz (Philips Healthcare, Bothell, WA) were used. The image depth was adjusted to 3 to 4 cm according to the size of the carotid artery, and the focus position was set at the level of the carotid artery. The time-gain compensation was adjusted to achieve a homogeneous signal intensity in the carotid artery while reducing noise from the wall of the artery and plaque. All of these settings were kept constant throughout each examination. A time-intensity curve analysis was performed with QLAB software (Philips Healthcare).
Methods
General patient information, including height, body mass, blood pressure, heart rate, and left ventricular ejection fraction, was measured, and the body mass index was calculated. The diagnosis of hypertension was matched with the hypertension diagnostic criteria issued by the World Health Organization/International Society of Hypertension in 1999. 11, 12 The diagnosis of diabetes was in accordance with the Diabetes Diagnosis and Treatment Guideline issued by the American Diabetes Association in 2013 13, 14 : glycated hemoglobin A 1C , 6.5% or higher; fasting plasma glucose, 7.0 mmol/L or higher; oral glucose tolerance test 2-hour glucose, 11.1 mmol/L or higher; or random blood glucose, 11.1 mmol/L or higher. The standards for dyslipidemia (in accordance with the 2007 domestic version of Dyslipidemia Prevention and Treatment Guideline for Chinese Adults 15, 16 were as follows: total cholesterol, 5.18 mmol/L or higher; triglycerides, 1.7 mmol/L or higher; high-density lipoprotein cholesterol, lower than 1.04 mmol/L; and low-density lipoprotein cholesterol, 3.37 mmol/L or higher. Smokers were defined as those who consumed at least 1 cigarette per day consecutively for 1 year or longer. 17 Serum High-Sensitivity C-Reactive Protein Assay A 3-mL volume of fasting venous blood was drawn in the morning and placed into a common dry test tube, and a latex-enhanced immunoturbidimetric assay was performed immediately to measure the serum highsensitivity C-reactive protein (CRP) level.
Two-Dimensional US
The patient was placed in a low-pillow decubitus position with the head slightly falling backward and the relaxed neck inclined contralateral to the side of the examination. The bilateral common carotid arteries, bifurcations of the common carotid arteries, external carotid artery, and internal carotid artery were scanned to observe plaque formation. If a plaque existed, the maximum plaque thickness was measured in a short-axis section. If more than 1 plaque was found in the carotid artery, the plaque with the maximum thickness was included as the study object. The plaque thickness was larger than 2.0 mm.
The plaques were classified according to their echo characteristics as follows: (1) soft plaque, with hypoechoic intensity relative to the peripheral vascular adventitia but no acoustic shadow (hypoechoic area > 80% of the plaque area); (2) hard plaque, with isoechoic or hyperechoic intensity relative to the peripheral vascular adventitia and an acoustic shadow (hyperechoic area->80% of the plaque area); (3) calcified plaque, with hyperechoic intensity accompanied by a posterior acoustic shadow (calcified area > 90% of the plaque area); and (4) mixed plaque, with no acoustic shadow, a calcified area of less than 90% of the plaque area, and an anechoic zone of less than 80% of the plaque area.
Contrast-Enhanced US
The sulfur hexafluoride microbubble contrast agent SonoVue (Bracco, Geneva, Switzerland) was used as the contrast material. The contrast material was administered intravenously as a 1.5-mL bolus through the antecubital vein within 2 to 3 seconds, followed by a saline bolus of 2 to 3 mL. A real-time contrast-enhanced cine loop was acquired after injection of the contrast material, including images obtained at least 3 seconds before and 5 minutes after the appearance of the contrast effect in the lumen of the carotid artery. 18, 19 The cine loop was digitally stored for later analysis. The patients were observed for any complications for 30 minutes before leaving ( Figure 1 ).
Analysis of Contrast-Enhanced US Images
Plaque enhancement was observed by the naked eye initially, time-intensity curve analysis software was started, and then a region of interest (ROI) with and identical size, shape, and position as those of the plaque was depicted artificially. 20 The ROI was the entire plaque, and the plaque enhancement intensity represented the blood volume of neovascularization inside the plaque: namely, the intensity of plaque contrast enhancement. Another ROI of 3 3 3 mm was placed inside the carotid lumen near the plaque as the control. Dynamic tracking was conducted for the ROI to maintain it at the nearly identical anatomic location on the image with contrast agent filling, thereby establishing the time-intensity curve ( Figure 2 ). According to the perfusion formula of
21 the contrast-time signal strength (Y), signal intensity increase rate (k), peak signal intensity (A), and basal tissue strength (B) were calculated. A was the maximum number of microbubbles that local tissues could accumulate, reflecting the local microvascular density and representing the capillary volume. 22 
Reproducibility of Contrast-Enhanced US Study Data
Interobserver and intraobserver variability of the measurements was assessed in 20 randomly selected patients (10 in each group). To assess intraobserver variability, the same observer (C.Q.) measured the 3-dimensional strain analysis twice at an interval of 3 days to avoid a recall bias. To assess interobserver variability, 3-dimensional strain measurements were performed by a second observer (L.Z.), who was blinded to the results of the first observer (C.Q.).
Statistical Analyses
Statistical analyses were performed with SPSS version 13.0 software (IBM Corporation, Armonk, NY). Quantitative variables were expressed as means 6 standard deviations, and qualitative variables were expressed as percentages. Measurement and enumeration data were compared by a t test and v 2 test. The predictive values of the peak signal intensity and plaque ratio for ACS according to a receiver operating characteristic curve analysis were calculated, as well as the sensitivity and specificity. A logistic regression analysis was performed for the correlation between CHD and plaque enhancement and its risk factors. A linear correlation analysis was performed for corresponding indicators, and the correlation was expressed as the Pearson correlation coefficient. P < .05 was considered statistically significant.
Results
Comparison of the Clinical Data Between the ACS and Stable CAD Groups
The ACS group included 41 male and 19 female patients with a mean age of 64.12 6 9.45 years (range, 45-82 years). The control group included 39 male and 21 female patients with a mean age of 61.32 6 9.17 years (range, 45-84 years). The ages, heart rates, sex ratios, body mass indices, and left ventricular ejection fractions of the patients in the ACS stable CAD groups were compared, and the differences were not statistically significant ( Table 1) .
Comparison of the Risk Factors Between the ACS and Stable CAD Groups
The proportions of diabetic patients, hypertensive patients, and smokers, as well as the levels of total cholesterol, high-density lipoprotein cholesterol, low-density lipoprotein cholesterol, triglycerides, and high-sensitivity CRP in the ACS and stable CAD groups were compared. The low-density lipoprotein cholesterol and highsensitivity CRP levels in the ACS group were higher than those in the stable CAD group, and the difference was statistically significant ( Table 2) .
Comparison of Carotid Plaque Classifications
Between the ACS and Stable CAD Groups The carotid plaque classifications between the ACS and stable CAD groups were compared. There were 49 cases of soft plaques (81%), 2 cases of hard plaques, 7 cases of mixed plaques, and 2 cases of calcified plaques in the ACS group; the stable CAD group had 32 cases of soft plaques (53%), 7 cases of hard plaques, 15 cases of mixed plaques and 6 cases of calcified plaques. The proportion of soft plaques in the ACS group was higher than that in the stable CAD group, and the difference was statistically significant (Table 3 ). 
Comparison of the Visual Inspection Results and Contrast-Enhanced US Parameters for Carotid Plaques Between the ACS and Stable CAD Groups
The number of cases with carotid plaque enhancement, peak signal intensity, and plaque-to-carotid lumen enhancement intensity ratio between the ACS and stable CAD groups were compared. The proportion of plaque enhancement, peak signal intensity, and enhancement intensity ratio in the ACS group were higher than those in the stable CAD group, and the difference was statistically significant (Table 4) . Values are expressed as mean 6 SD where applicable. 
Analysis of the Correlation Between the Intensity of Contrast Enhancement in Carotid Plaques and the High-Sensitivity CRP Level in the ACS Group
The correlation between the serum high-sensitivity CRP concentration and peak signal intensity of carotid plaques in the ACS group was studied. The correlation coefficient obtained from the Pearson linear correlation analysis of the serum high-sensitivity CRP level and peak signal intensity of carotid plaques was 0.875, indicating that the contrast enhancement intensity within carotid plaques was correlated with the serum high-sensitivity CRP level (Figure 3 ).
Comparison of Receiver Operating Characteristic Curves
In the receiver operating characteristic curve analysis, the sensitivity and specificity of the peak signal intensity of carotid plaques were 80.0% and 88.3%, respectively (cutoff value, 9.97 dB; area under the curve, 0.865; Figure 4) .
Analysis of the Correlation Between ACS and the Plaque Enhancement Intensity as Well as Other Factors
A binary classification logistic regression analysis was conducted on the correlation between ACS and the peak signal intensity, age, sex, body mass index, diabetes, hypertension, smoking, dyslipidemia, and highsensitivity CRP level. The conclusion was that the occurrence of ACS was correlated with age (65-74 years), the high-sensitivity CRP level, and the plaque peak signal intensity (Table 5) .
Intraobserver and Interobserver Variability
The intraobserver and interobserver variability data are shown in Tables 6 and 7 .
Discussion
The clinical manifestation of coronary atherosclerosis is CHD. Vulnerable coronary plaques are closely related to ACS, and carotid atherosclerostic plaques have a similar pathologic basis as coronary plaques. Neovascularization in plaques was identified after studies concerning its major characteristic of plaque instability and its status as Values are expressed as mean 6 SD where applicable. Values are expressed as mean 6 SD where applicable.
Qin et al-Carotid Plaque Neovascularization on Contrast-Enhanced US an independent predictor of ACS, eventually resulting in plaque rupture and hemorrhage, with a close correlation with the occurrence of clinical cardiovascular events. 23, 24 Detecting the correlation between the degree of plaque enhancement and the density of neovascularization in plaques by contrast-enhanced US can provide rating information for the risk of carotid plaques. Contrastenhanced US can highlight neovascularization within carotid plaques and provide qualitative and quantitative assessments of plaque vulnerability in real time, compensating for the shortcomings of conventional examination methods. 25 Prevalence of Stable CAD in Patients With ACS From the initial autopsy series, stable CAD was thought to be a very rare cause of CAD, mainly occurring in young women without classic coronary risk factors. Angiographic studies also reported that the prevalence of stable CAD varied from 0.07% to 0.24% in patients with CAD 24,25 but was still rare. The data suggested that the prevalence of stable CAD in ACS might be greater than expected. In our study, the number of soft plaque cases in the ACS group was greater than that in the stable CAD group, and the proportion of plaque enhancement in the ACS group was higher than that in the stable CAD group; both findings resulted from the higher density of neovascularization in vulnerable plaques than in stable plaques. 26, 27 The higher low-density lipoprotein cholesterol level in the ACS group than in the stable CAD group and the elevated blood cholesterol level gradually promoted the formation of a plaque lipid core as well as plaque neovascularization due to the division and proliferation of vascular endothelial cells. 28, 29 Neovascularization promoted the growth of plaques, and internal hemorrhage and inflammation resulted from the incomplete endothelial structure and Figure 4 . Comparison of receiver operating characteristic curves for the peak signal intensity (A) and ratio. The sensitivity and specificity of the peak signal intensity in carotid plaques were 80.0% and 88.3%, respectively (cutoff value, 9.97 dB; area under the curve, 0.865). Values are expressed as mean 6 SD where applicable. Values are expressed as mean 6 SD where applicable.
Qin et al-Carotid Plaque Neovascularization on Contrast-Enhanced US insufficient pericytes and smooth muscle cells of neovascularization, in addition to the increased permeability and fragility of neovascularization. 30, 31 Followed by the formation and accelerated damage of unstable plaques, rupture and hemorrhage of unstable plaques finally occurred and led to cardiovascular diseases. 32 Contrast-Enhanced US of Atherosclerosis Contrast-enhanced US has been used to detect neovascularization in carotid plaques. Initial studies have shown that qualitative assessments of plaque neovascularization, as detected with contrast-enhanced US, correlate with histologically determined microvascular density and to plaque echogenicity, the latter being a marker of plaque vulnerability. 17, [20] [21] [22] [23] Similarly, quantitative data on plaque neovascularization obtained by maximum intensity projection methods have been shown to correlate with histologic neovascularization and inflammatory cell infiltration. As one of the most sensitive and specific indicators of the state of chronic inflammation, high-sensitivity CRP is involved in the formation and development of carotid neovascularization in patients with CHD and is suitable as an important determinant of neovascularization. In this study, we found that the high-sensitivity CRP level in the ACS group was higher than that in the stable CAD group, and it was positively correlated with the contrast enhancement intensity. Therefore, this study also confirmed the relevance between the neovascularization of carotid plaques and inflammatory responses in ACS. In addition, the plaque contrast enhancement intensity showed relatively high sensitivity and specificity in predicting ACS. The contrast enhancement intensity is an independent risk factor for the occurrence of ACS and has substantial clinical importance for the prevention and treatment of ACS. The vascular endothelial function decreases, and the permeability of endothelial cells increases with increasing age. 33 The adhesion of inflammatory cells, movement of endothelial cells toward subendothelial tissues, and proliferation of smooth muscle cells lead to the formation of plaques. 34 The repeatability of the quantitative time-intensity curve analysis software was researched in this study. The results indicated that the software has good measurement repeatability and can evaluate the micro blood perfusion of neovascularization within carotid plaques in a relatively stable manner.
Limitations
This study had some limitations. First, it was a singlecenter study with a relatively small number of patients. A larger number of events is needed for adequate statistical power to fully evaluate whether a novel risk marker contributes additional prognostic information to an established set of risk factors in a multivariate model, as opposed to simply indicating whether the new marker is prognostic by itself. Another limitation was that only the thickest plaque was observed and analyzed in patients with multiple carotid plaques on conventional and contrast-enhanced US.
Conclusions
Contrast enhancement in plaques was more common in patients with ACS than in those with stable CAD. Carotid plaque enhancement on contrast-enhanced US could thus represent a predictor of future coronary events, if our results can be confirmed in further prospective studies.
